An exciting day for patients and the biotech ecosystem in Canada! A CA$701 million co-investment by AbCellera and the Governments of Canada & British Columbia to build state-of-the-art facilities & technologies to bring new antibody therapies from disease target to the clinic. The project includes up to 17 new development programs and multiple Phase 1 clinical trials to be conducted in British Columbia and across Canada!
AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients http://ow.ly/Tkte50OvQiS
